Med-E.R.R.S.^®

The Institute of Medicine (IOM) reports related to healthcare and medication safety, as well as tougher FDA standards, have become motivating factors for pharmaceutical and technology companies to improve their pre-marketing safety testing and post-marketing safety surveillance. Med-E.R.R.S., Inc.^® stands ready to assist global pharmaceutical and healthcare technology companies in evaluating the safety of their products, both pre-launch and post-marketing.

During the product development stage, use of the Med-E.R.R.S. services can help pharmaceutical companies develop trademarks and package labels designed to lower the risk of medication errors. These can also be applied to assist technology companies in improving the safety of their medication use systems. Post-marketing, Med-E.R.R.S. can monitor and analyze adverse events to determine if a medication error caused the event.

[Who We Are]   [Med-E.R.R.S. brochure]